Plain-English translation of NCT04392401 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to understand exactly how the immune system reacts when COVID-19 becomes severe enough to require intensive care. By collecting blood samples from hospitalized patients early in their stay and tracking changes over time, the study aims to identify patterns that could guide new treatment approaches and help predict which patients are at highest risk of complications.
Some COVID-19 patients develop life-threatening lung damage and organ failure, and many develop secondary infections that can be fatal. Doctors don't yet fully understand what happens with the immune system during severe COVID-19, which makes it hard to know how to best treat it. This study will fill that gap by carefully documenting the immune changes that occur.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will have blood samples collected during your intensive care stay—starting within your first 24 hours in the unit. These samples will be analyzed to track how your immune system changes over time. The study is observational, meaning researchers are watching and measuring rather than giving you a new treatment; your regular ICU care continues as normal.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
France